Chronic Pain

The Texas House approved expansions to the state’s medical cannabis program that would raise the THC limit from 0.5% to 5% and legalize access for patients with chronic pain, PTSD, and cancer.

A recently published German study showed that cannabis could be a promising treatment for reducing pain and muscle cramps in Parkinson’s patients.

A recent survey of 525 chronic pain patients found that 40.4% of respondents had replaced their opioid-based medications with medical cannabis.

The University of Pittsburgh has announced a 10-year research program with medical cannabis company Parallel (formerly Surterra Wellness).

More and more, CBD consumers tout the compound’s effectiveness at alleviating the symptoms of chronic pain. Let’s dive into the relationship between CBD and chronic pain, and how one might use CBD products to help reduce pain symptoms.

Minnesota health officials have approved chronic pain and a degenerative eye condition as new qualifying conditions for the state’s medical cannabis program.

Connecticut health officials have recommended adding chronic pain and Ehlers-Danlos syndrome as qualifying conditions for the state’s medical cannabis program.

Researchers at the University of Guelph in Ontario say they have identified pain-relieving cannabis flavonoids that are “30 times more powerful at reducing inflammation than Aspirin.”

A recent study shows that nearly two-thirds of military veterans in California have replaced prescription medications with cannabis in the treatment of chronic pain, anxiety, PTSD, depression, and insomnia.

An analysis of state-legal medical cannabis programs shows that 85% of the reasons reported for seeking medical cannabis show conclusive scientific evidence that cannabis is an effective treatment.

The study, conducted in the Netherlands, found evidence that THC extract from cannabis is useful as a treatment for fibromyalgia pain. Notably, researchers suggest it is far more effective than purely CBD extract.